Robert O. Dillman
Researcher Next ID · RN-040721
Researcher · Biochemistry, Genetics and Molecular Biology
Westport, Ireland
- Works count
- 322
- Citation count
- 8,298
- H-index
- 43
- i10-index
- 139
Research interests
Publications
Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses
Journal for ImmunoTherapy of Cancer · 2018 · 10.1186/s40425-018-0330-1
Tumor Stem Cell Antigens as Consolidative Active Specific Immunotherapy
Journal of Immunotherapy · 2012 · 10.1097/cji.0b013e31826f79c8
Defining the critical hurdles in cancer immunotherapy
Journal of Translational Medicine · 2011 · 10.1186/1479-5876-9-214
Cancer Immunotherapy
Cancer Biotherapy and Radiopharmaceuticals · 2011 · 10.1089/cbr.2010.0902
Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma
Journal of Immunotherapy · 2009 · 10.1097/cji.0b013e3181b2910f
Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress
Journal of Clinical Oncology · 2008 · 10.1200/jco.2007.15.7438
Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer
Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.05.5335
Intracavitary Placement of Autologous Lymphokine-Activated Killer (LAK) Cells after Resection of Recurrent Glioblastoma
Journal of Immunotherapy · 2004 · 10.1097/00002371-200409000-00009
Radiolabeled Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoma
Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.02.126
Infusion Reactions Associated with the Therapeutic Use of Monoclonal Antibodies in the Treatment of Malignancy
Cancer and Metastasis Reviews · 1999 · 10.1023/a:1006341717398
Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab
Journal of Clinical Oncology · 1999 · https://doi.org/10.1200/jco.1999.17.6.1851
Inpatient continuous-infusion interleukin-2 in 788 patients with cancer the national biotherapy study group experience
Cancer · 1993 · 10.1002/1097-0142(19930401)71:7<2358::aid-cncr2820710730>3.0.co;2-m
Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial
Cancer · 1991 · 10.1002/1097-0142(19910701)68:1<1::aid-cncr2820680102>3.0.co;2-k
Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial.
Journal of Clinical Oncology · 1991 · 10.1200/jco.1991.9.7.1233
Phase I clinical comparative study of monoclonal antibody KS1/4 and KS1/4-methotrexate immunconjugate in patients with non-small cell lung carcinoma.
PubMed · 1990
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
New England Journal of Medicine · 1990 · https://doi.org/10.1056/nejm199010043231403
Monoclonal Antibodies for Treating Cancer
Annals of Internal Medicine · 1989 · 10.7326/0003-4819-111-7-592
Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.
Journal of Clinical Oncology · 1989 · 10.1200/jco.1989.7.4.433
Tumor size: effect on monoclonal antibody uptake in tumor models.
PubMed · 1986
Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report.
Radiology · 1985 · 10.1148/radiology.155.2.3983401
Human immune response to multiple injections of murine monoclonal IgG.
The Journal of Immunology · 1985 · https://doi.org/10.4049/jimmunol.135.2.1530
Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.
Journal of Clinical Oncology · 1984 · 10.1200/jco.1984.2.8.881
Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells.
PubMed · 1984
Lead poisoning from a gunshot wound
The American Journal of Medicine · 1979 · 10.1016/0002-9343(79)91083-0
Current projects
No projects listed.